Sutro Biopharma, Inc. (STRO) vs Entrada Therapeutics, Inc. (TRDA)
- Sutro Biopharma, Inc. STRO 10.87 −5.15%
- Entrada Therapeutics, Inc. TRDA 4.36 −8.79%
Sutro Biopharma, Inc. and Entrada Therapeutics, Inc. are both Biotechnology companies. Sutro Biopharma, Inc. and Entrada Therapeutics, Inc. are of similar size ($190.0M and $186.1M). Sutro Biopharma, Inc. grew revenue faster over the last twelve months: −56.3% against −94.1%. Sutro Biopharma, Inc. has the higher net margin (−395.3% vs −3,537.7%) and the higher return on invested capital (0.00% vs −1,060.2%). Across the 14 metrics below, Sutro Biopharma, Inc. leads on 9 and Entrada Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | STRO | TRDA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (319.57%) | (3,767.07%) | 0.00% |
| Net margin | (395.25%) | (3,537.73%) | 0.00% |
| Free cash flow margin | (318.63%) | (2,867.07%) | 0.00% |
| Return on equity | 266.76% | (54.09%) | (56.36%) |
| Return on assets | (79.08%) | (44.35%) | (48.04%) |
| Return on invested capital | 0.00% | (1,060.24%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack